Insider · CIK 0001751100
Jeffrey Scott Cole
Files at CVKD (Cadrenal Therapeutics, Inc.). First filing -, latest -.
In brief
Jeffrey Scott Cole files SEC Form 4 as COO at CVKD (Cadrenal Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jeffrey Scott Cole has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 23, 2025 | CVKD Cadrenal Therapeutics, Inc. | AGrant or award Stock Optionsderivative | +25,000 | $0.00 | $0 | 25,000 | Jan 24, 2025 |
Questions about Jeffrey Scott Cole
Answered from the filings on this page, as of the latest one.
Is Jeffrey Scott Cole buying or selling?
Jeffrey Scott Cole has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jeffrey Scott Cole's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeffrey Scott Cole has 0.
Where does Jeffrey Scott Cole file Form 4?
Jeffrey Scott Cole has filed Form 4 at CVKD (Cadrenal Therapeutics, Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.